Pacific Biosciences of California Current Deferred Revenue (Quarterly) Analysis

Pacific Biosciences of California, Inc. (PACB)

1.71 -0.06 (-3.39%) USD | NASDAQ | Dec 29, 16:00

1.71 0.00 (0.00%) After-Hours: 20:00

View Current Deferred Revenue (Quarterly) for PACB.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

Bruker Corp.	Upgrade
ICU Medical, Inc.	Upgrade
West Pharmaceutical Services, Inc.	--
Clearpoint Neuro, Inc.	Upgrade
Intellia Therapeutics, Inc.	Upgrade